Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.84% | 18.75% | 15.45% | 24.99% | 22.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.84% | 18.75% | 15.45% | 24.99% | 22.88% |
| Cost of Revenue | 5.68% | 19.49% | 14.85% | 24.24% | 21.29% |
| Gross Profit | 6.18% | 17.12% | 16.86% | 26.73% | 26.60% |
| SG&A Expenses | 4.96% | 19.32% | 12.31% | 36.54% | 19.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 68.99% | -101.68% | 0.77% | -96.64% | -1,417.02% |
| Total Operating Expenses | 5.93% | 18.86% | 14.16% | 26.18% | 19.99% |
| Operating Income | 4.09% | 16.80% | 46.44% | 4.27% | 119.43% |
| Income Before Tax | -1.11% | -1.29% | 376.72% | -18.44% | 119.34% |
| Income Tax Expenses | 150.24% | 41.66% | 152.49% | -20.33% | -80.43% |
| Earnings from Continuing Operations | -24.18% | -24.66% | 3,064.05% | -16.84% | 494.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.18% | -24.66% | 3,064.05% | -16.84% | 494.66% |
| EBIT | 4.09% | 16.80% | 46.44% | 4.27% | 119.43% |
| EBITDA | 11.41% | 11.99% | -10.00% | 27.44% | 67.46% |
| EPS Basic | -23.81% | -25.23% | 2,600.00% | -16.67% | 493.75% |
| Normalized Basic EPS | -1.10% | 0.00% | 385.71% | -18.56% | 121.95% |
| EPS Diluted | -23.81% | -25.23% | 2,600.00% | -16.67% | 493.75% |
| Normalized Diluted EPS | -1.10% | 0.00% | 385.71% | -18.56% | 121.95% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
